A new study from Washington University School of Medicine and the Veterans Affairs St. Louis Health Care system found that repeat SARS-CoV-2 infections contribute significant additional risk of adverse health conditions in multiple organ systems.
Rejuvenating the immune cells that live in tissues surrounding the brain improves fluid flow and waste clearance from the brain — and may help treat or even prevent neurodegenerative diseases such as Alzheimer’s and Parkinson’s, according to a study by researchers at Washington University School of Medicine.
Lindsay Stark, a professor at the Brown School, has received a one-year $435,000 grant from UNICEF for a project titled “Intervention Review and Implementation Research to Address Gender-based Violence in Emergencies.”
The U.S. Department of Health and Human Services has awarded researchers Ellen Fitzsimmons-Craft and Denise Wilfley a grant to help improve outcomes for eating disorders in adolescent girls.
School of Medicine scientists have received a five-year $11.7 million grant to study human genes and nerve cells to better understand how cells transmit pain and to find new ways to treat it.
A study from Washington University School of Medicine shows that as patients age, Huntington’s disease impairs autophagy, which eliminates waste from cells.
Researchers at the School of Medicine are working toward a treatment for neurodegenerative diseases, among them peripheral neuropathies and Parkinson’s disease, that targets SARM1, a key molecule in the death of axons, the wiring of the nervous system.
Faculty members Song Hu and Yong Wang are teaming up to find quantitative biomarkers for clinical pain management.
Abhinav Jha and a group of interdisciplinary collaborators have developed a method to measure dopamine transporter, a protein related to movement and Parkinson’s disease.
Carlos Cruchaga, at the School of Medicine, has received a 2022 Zenith Fellow Award from the Alzheimer’s Association. The annual award is given to scientists who have made significant contributions to Alzheimer’s disease research and are likely to continue to do so.